List of Tables
    Table 1. Bipolar Disorder Therapeutics Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Bipolar Disorder Therapeutics Drugs Market Trends
    Table 3. Bipolar Disorder Therapeutics Drugs Market Drivers
    Table 4. Bipolar Disorder Therapeutics Drugs Market Challenges
    Table 5. Bipolar Disorder Therapeutics Drugs Market Restraints
    Table 6. Global Bipolar Disorder Therapeutics Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Bipolar Disorder Therapeutics Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Bipolar Disorder Therapeutics Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Bipolar Disorder Therapeutics Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Bipolar Disorder Therapeutics Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Bipolar Disorder Therapeutics Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Bipolar Disorder Therapeutics Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Bipolar Disorder Therapeutics Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Bipolar Disorder Therapeutics Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Bipolar Disorder Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Bipolar Disorder Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder Therapeutics Drugs as of 2021)
    Table 18. Top Players of Bipolar Disorder Therapeutics Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Bipolar Disorder Therapeutics Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Bipolar Disorder Therapeutics Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Bipolar Disorder Therapeutics Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Bipolar Disorder Therapeutics Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Bipolar Disorder Therapeutics Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Bipolar Disorder Therapeutics Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Bipolar Disorder Therapeutics Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Bipolar Disorder Therapeutics Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Bipolar Disorder Therapeutics Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Bipolar Disorder Therapeutics Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Bipolar Disorder Therapeutics Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Bipolar Disorder Therapeutics Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Bipolar Disorder Therapeutics Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Bipolar Disorder Therapeutics Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Bipolar Disorder Therapeutics Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Bipolar Disorder Therapeutics Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Bipolar Disorder Therapeutics Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Bipolar Disorder Therapeutics Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. AstraZeneca Corporation Information
    Table 43. AstraZeneca Description and Business Overview
    Table 44. AstraZeneca Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. AstraZeneca Bipolar Disorder Therapeutics Drugs Product
    Table 46. AstraZeneca Recent Development
    Table 47. Allergan Corporation Information
    Table 48. Allergan Description and Business Overview
    Table 49. Allergan Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Allergan Product
    Table 51. Allergan Recent Development
    Table 52. Bristol-Myers Squibb Corporation Information
    Table 53. Bristol-Myers Squibb Description and Business Overview
    Table 54. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Bristol-Myers Squibb Product
    Table 56. Bristol-Myers Squibb Recent Development
    Table 57. GSK Corporation Information
    Table 58. GSK Description and Business Overview
    Table 59. GSK Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. GSK Product
    Table 61. GSK Recent Development
    Table 62. Janssen Corporation Information
    Table 63. Janssen Description and Business Overview
    Table 64. Janssen Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Janssen Product
    Table 66. Janssen Recent Development
    Table 67. AbbVie Corporation Information
    Table 68. AbbVie Description and Business Overview
    Table 69. AbbVie Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. AbbVie Product
    Table 71. AbbVie Recent Development
    Table 72. Youdim Corporation Information
    Table 73. Youdim Description and Business Overview
    Table 74. Youdim Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Youdim Product
    Table 76. Youdim Recent Development
    Table 77. Delpor Corporation Information
    Table 78. Delpor Description and Business Overview
    Table 79. Delpor Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Delpor Product
    Table 81. Delpor Recent Development
    Table 82. Lundbeck Corporation Information
    Table 83. Lundbeck Description and Business Overview
    Table 84. Lundbeck Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Lundbeck Product
    Table 86. Lundbeck Recent Development
    Table 87. Intra-Cellular Therapies Corporation Information
    Table 88. Intra-Cellular Therapies Description and Business Overview
    Table 89. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Intra-Cellular Therapies Product
    Table 91. Intra-Cellular Therapies Recent Development
    Table 92. Novartis Pharmaceuticals Corporation Corporation Information
    Table 93. Novartis Pharmaceuticals Corporation Description and Business Overview
    Table 94. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Novartis Pharmaceuticals Corporation Product
    Table 96. Novartis Pharmaceuticals Corporation Recent Development
    Table 97. Noven Pharmaceuticals Corporation Information
    Table 98. Noven Pharmaceuticals Description and Business Overview
    Table 99. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Noven Pharmaceuticals Product
    Table 101. Noven Pharmaceuticals Recent Development
    Table 102. Otsuka Corporation Information
    Table 103. Otsuka Description and Business Overview
    Table 104. Otsuka Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. Otsuka Product
    Table 106. Otsuka Recent Development
    Table 107. Pfizer Corporation Information
    Table 108. Pfizer Description and Business Overview
    Table 109. Pfizer Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Pfizer Product
    Table 111. Pfizer Recent Development
    Table 112. Reviva Pharmaceuticals Corporation Information
    Table 113. Reviva Pharmaceuticals Description and Business Overview
    Table 114. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Reviva Pharmaceuticals Product
    Table 116. Reviva Pharmaceuticals Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Bipolar Disorder Therapeutics Drugs Customers List
    Table 120. Bipolar Disorder Therapeutics Drugs Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bipolar Disorder Therapeutics Drugs Product Picture
    Figure 2. Global Bipolar Disorder Therapeutics Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Bipolar Disorder Therapeutics Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Bipolar Disorder Therapeutics Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Bipolar Disorder Therapeutics Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Bipolar Disorder Therapeutics Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Bipolar Disorder Therapeutics Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Bipolar Disorder Therapeutics Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Bipolar Disorder Therapeutics Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Bipolar Disorder Therapeutics Drugs Report Years Considered
    Figure 11. Product Picture of Olanzapine (Zyprexa)
    Figure 12. Product Picture of Quetiapine (Seroquel)
    Figure 13. Product Picture of Risperidone (Risperdal)
    Figure 14. Product Picture of Ariprazole (Abilify)
    Figure 15. Product Picture of Ziprasidone (Geodon)
    Figure 16. Product Picture of Clozapine (Clozaril)
    Figure 17. Global Bipolar Disorder Therapeutics Drugs Market Share by Type in 2022 & 2028
    Figure 18. Global Bipolar Disorder Therapeutics Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 19. Global Bipolar Disorder Therapeutics Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 20. Global Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2028) & (K Units)
    Figure 21. Global Bipolar Disorder Therapeutics Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 22. Global Bipolar Disorder Therapeutics Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 23. United States Bipolar Disorder Therapeutics Drugs Market Share by Type in 2022 & 2028
    Figure 24. United States Bipolar Disorder Therapeutics Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 25. United States Bipolar Disorder Therapeutics Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 26. United States Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2028) & (K Units)
    Figure 27. United States Bipolar Disorder Therapeutics Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 28. United States Bipolar Disorder Therapeutics Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 29. Product Picture of lumateperone
    Figure 30. Product Picture of Central Nervous System (CNS) Disorders
    Figure 31. Global Bipolar Disorder Therapeutics Drugs Market Share by Application in 2022 & 2028
    Figure 32. Global Bipolar Disorder Therapeutics Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Bipolar Disorder Therapeutics Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2028) & (K Units)
    Figure 35. Global Bipolar Disorder Therapeutics Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Bipolar Disorder Therapeutics Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 37. United States Bipolar Disorder Therapeutics Drugs Market Share by Application in 2022 & 2028
    Figure 38. United States Bipolar Disorder Therapeutics Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Bipolar Disorder Therapeutics Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2028) & (K Units)
    Figure 41. United States Bipolar Disorder Therapeutics Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Bipolar Disorder Therapeutics Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 43. North America Bipolar Disorder Therapeutics Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. North America Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Bipolar Disorder Therapeutics Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 48. Europe Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 55. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Bipolar Disorder Therapeutics Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 67. Latin America Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 72. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Bipolar Disorder Therapeutics Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Bipolar Disorder Therapeutics Drugs Value Chain
    Figure 77. Bipolar Disorder Therapeutics Drugs Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed